These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


552 related items for PubMed ID: 16421365

  • 1. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
    Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC.
    N Engl J Med; 2006 Jan 19; 354(3):241-50. PubMed ID: 16421365
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.
    Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, King M, Bye PT.
    Thorax; 1997 Oct 19; 52(10):900-3. PubMed ID: 9404379
    [Abstract] [Full Text] [Related]

  • 11. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M, Dentice R.
    Cochrane Database Syst Rev; 2020 Feb 28; 2(2):CD008816. PubMed ID: 32107770
    [Abstract] [Full Text] [Related]

  • 12. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.
    Robinson M, Daviskas E, Eberl S, Baker J, Chan HK, Anderson SD, Bye PT.
    Eur Respir J; 1999 Sep 28; 14(3):678-85. PubMed ID: 10543292
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA, McDonald V, Jones AP.
    Cochrane Database Syst Rev; 2005 Jul 20; (3):CD001506. PubMed ID: 16034863
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    Knowles MR, Church NL, Waltner WE, Yankaskas JR, Gilligan P, King M, Edwards LJ, Helms RW, Boucher RC.
    N Engl J Med; 1990 Apr 26; 322(17):1189-94. PubMed ID: 2157983
    [Abstract] [Full Text] [Related]

  • 20. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF.
    Pediatr Pulmonol; 1996 Feb 26; 21(2):77-83. PubMed ID: 8882210
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.